Generative AI and Multi-Omics Integration in Drug Discovery
This special issue belongs to the section "Biosignal Processing".
Special Issue Information
Dear Colleagues,
The conventional drug discovery pipeline is frequently obstructed by high costs, extended development timelines, and significant attrition rates in clinical trials. In recent years, the convergence of Generative Artificial Intelligence (AI) and multi-omics technologies, including genomics, proteomics, and metabolomics, has emerged as a transformative paradigm in bioengineering. This integration enables the systematic decoding of complex biological systems, facilitating the precise identification of novel therapeutic targets and the rational design of biologics and small-molecule drugs.
This Special Issue aims to highlight cutting-edge research at the intersection of AI, multi-omics, and pharmaceutical bioengineering. We welcome original research articles and comprehensive reviews focusing on, but not limited to, the following topics:
- Generative models (e.g., diffusion models, GANs, and large language models) for de novo molecular and protein design.
- Multi-omics data integration frameworks for target identification and patient stratification.
- AI-driven bioengineering applications, including enzyme engineering, antibody design, and optimization of therapeutic properties.
- Machine learning approaches for predicting drug-target interactions, polypharmacology, and ADMET properties.
- Systems biology approaches combining computational modeling with experimental validation in drug development.
We invite investigators to contribute to this Special Issue, fostering interdisciplinary discussions that bridge computational innovation with experimental bioengineering to accelerate the future of drug discovery.
Dr. Chin-Hung Lai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- multi-omics integration
- drug discovery and development
- bioengineering and biotechnology
- computational drug design
- systems biology
- machine learning in pharmaceuticals
- therapeutic target identification
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

